What you need to know about Lecanemab

 

Learn more about the Alzheimer’s drug Lecanemab (marketed as Leqembi), which just received accelerated approval from the FDA.

Watch Alzheimer’s Orange County CEO, Jim McAleer and CMO of Irvine Clinical Research, Dr. Trinh explain the science behind the new Alzheimer’s drug and how it works.

*Video recorded on December 2022 prior to the drug’s FDA approval